LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,279 | +14.4% | 27,050 | -0.7% | 0.01% | +25.0% |
Q1 2024 | $1,992 | +2.4% | 27,250 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $1,946 | +18.7% | 27,250 | -0.4% | 0.00% | 0.0% |
Q3 2023 | $1,639 | -17.5% | 27,350 | -0.7% | 0.00% | 0.0% |
Q2 2023 | $1,986 | -2.4% | 27,550 | -0.4% | 0.00% | -20.0% |
Q1 2023 | $2,034 | +8.5% | 27,650 | -1.4% | 0.01% | 0.0% |
Q4 2022 | $1,874 | -99.9% | 28,050 | 0.0% | 0.01% | -16.7% |
Q3 2022 | $2,415,000 | -3.2% | 28,050 | +0.4% | 0.01% | 0.0% |
Q2 2022 | $2,494,000 | -20.4% | 27,950 | +0.4% | 0.01% | 0.0% |
Q1 2022 | $3,133,000 | -27.2% | 27,850 | 0.0% | 0.01% | -25.0% |
Q4 2021 | $4,302,000 | +11.7% | 27,850 | +0.7% | 0.01% | 0.0% |
Q3 2021 | $3,852,000 | +29.3% | 27,650 | +21.8% | 0.01% | +33.3% |
Q2 2021 | $2,978,000 | -14.0% | 22,700 | 0.0% | 0.01% | -14.3% |
Q1 2021 | $3,461,000 | +24.7% | 22,700 | -18.6% | 0.01% | +16.7% |
Q4 2020 | $2,775,000 | +4.0% | 27,900 | -0.4% | 0.01% | 0.0% |
Q3 2020 | $2,669,000 | -14.8% | 28,000 | 0.0% | 0.01% | -25.0% |
Q2 2020 | $3,132,000 | +53.8% | 28,000 | 0.0% | 0.01% | +33.3% |
Q1 2020 | $2,036,000 | -30.3% | 28,000 | 0.0% | 0.01% | -14.3% |
Q4 2019 | $2,920,000 | +5.1% | 28,000 | +0.4% | 0.01% | 0.0% |
Q3 2019 | $2,777,000 | -12.8% | 27,900 | 0.0% | 0.01% | -12.5% |
Q2 2019 | $3,185,000 | -9.2% | 27,900 | 0.0% | 0.01% | -11.1% |
Q1 2019 | $3,507,000 | -10.9% | 27,900 | -3.8% | 0.01% | -18.2% |
Q4 2018 | $3,935,000 | -62.3% | 29,000 | -23.7% | 0.01% | -54.2% |
Q3 2018 | $10,431,000 | +36.4% | 38,001 | +3.0% | 0.02% | +26.3% |
Q2 2018 | $7,645,000 | +25.9% | 36,901 | +0.4% | 0.02% | +26.7% |
Q1 2018 | $6,070,000 | +15.9% | 36,754 | -3.9% | 0.02% | +25.0% |
Q4 2017 | $5,238,000 | +2.0% | 38,254 | +1.4% | 0.01% | -7.7% |
Q3 2017 | $5,137,000 | +13.7% | 37,733 | +1.3% | 0.01% | +8.3% |
Q2 2017 | $4,520,000 | +9.4% | 37,233 | -4.6% | 0.01% | +9.1% |
Q1 2017 | $4,131,000 | +1.8% | 39,033 | -2.3% | 0.01% | 0.0% |
Q4 2016 | $4,058,000 | -4.9% | 39,933 | -4.5% | 0.01% | 0.0% |
Q3 2016 | $4,269,000 | -15.0% | 41,833 | -0.7% | 0.01% | -15.4% |
Q2 2016 | $5,025,000 | +20.5% | 42,133 | +8.2% | 0.01% | +18.2% |
Q1 2016 | $4,169,000 | -1.2% | 38,933 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $4,221,000 | +53.0% | 38,933 | +20.8% | 0.01% | +37.5% |
Q3 2015 | $2,759,000 | -2.1% | 32,216 | +15.3% | 0.01% | +14.3% |
Q2 2015 | $2,818,000 | +31.3% | 27,930 | +0.4% | 0.01% | +40.0% |
Q1 2015 | $2,146,000 | -21.2% | 27,830 | -45.6% | 0.01% | +66.7% |
Q4 2014 | $2,722,000 | +468.3% | 51,174 | +402.3% | 0.00% | +200.0% |
Q3 2014 | $479,000 | -20.6% | 10,188 | +5.2% | 0.00% | -50.0% |
Q2 2014 | $603,000 | -7.5% | 9,688 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $652,000 | +36.4% | 9,688 | +6.6% | 0.00% | +100.0% |
Q4 2013 | $478,000 | – | 9,088 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |